Richmond Pharmacology is excited to join the 11th Annual Outsourcing in Clinical Trials Korea 2026 in Seoul, South Korea, on 1–2 December 2026.

As a key regional meeting for clinical operations, outsourcing strategy, and partnership development, OCT Korea brings together leading sponsors, CROs, researchers, and innovative solution providers to explore best practices and real‑world insights shaping the future of clinical trials in Korea and the broader Asia‑Pacific region.

Representing Richmond Pharmacology

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Clinical operations strategy and trial optimisation in Asia‑Pacific
  • CRO partnerships, outsourcing models, and vendor management
  • Regulatory developments and study‑start‑up pathways in Korea
  • Patient recruitment approaches and site engagement practices
  • Innovations enhancing quality, efficiency, and trial delivery

Connect With Us

If you are attending OCT Korea 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: 11th Annual Outsourcing in Clinical Trials Korea 2026 - Arena International

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event